Form 4 for ELAN Elanco Animal Health Inc
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001415889-23-004278 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-03 | 2023-03-01 | ELAN | Modi Rajeev A. | SEE REMARKS | A - Grant | $0.00 | +23.3K | 66.4K | +54% | $0 |
| D | 2023-03-03 | 2023-03-01 | ELAN | Modi Rajeev A. | SEE REMARKS | A - Grant | $0.00 | +53.2K | 53.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | A | A | 23,313 | $0.00 | 66,355 | D | — | — | (F1) Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026. (F2) Includes 1,885 shares acquired under Elanco Animal Health Inc.'s Employee Stock Purchase Plan between September 30, 2022 and December 30, 2022. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-03-01 | A | A | 53,246 | $0.00 | 53,246 | D | $11.26 · — to 2033-03-01 | 53,246 Common Stock | (F3) Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026. |